BCL2 and acute kidney injury: Specifically, the positive rates of BAX, KIM-1, and BCL-2 in the AKI group were 33%, 60%, and 17%, respectively; those in the Akk d17 group were 26%, 57%, and 31%, respectively; and those in the control group were 19%, 42%, and 49%, respectively.